Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials-MedSci.cn

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

Zhou, KS; Sun, MY; Wei, X; Yi, SH; Qi, JY; Nian, WQ; Cui, GH; Wang, JS; Zhang, XP; Cen, H; Zhou, FL; Huang, JY; Liu, HL; Shen, AZ; Geng, LQ; Feng, R; Xu, CY; Qian, WB; Li, F; Liu, LH; Li, CX; Zhao, XL; Jin, J; Jing, HM; Ji, DM; Lyu, FF; Chen, Z; Men, LC; Wang, HB; Zhang, K; Xu, L; Zhang, Z; Yang, DJ; Wang, JX; Li, JY; Zhai, YF

BLOOD, 2023; 142 ():

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Updated Efficacy and Safety Results of Lisaftoclax (APG-2575) in Patients (Pts) with Heavily Pretreated Chronic Lymphocytic Leukemia (CLL): Pooled Analyses of Two Clinical Trials

科室

工具

服务